{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:29:55Z","timestamp":1787009395232,"version":"build-2736575974"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"JSPS","doi-asserted-by":"publisher","award":["20K08643"],"award-info":[{"award-number":["20K08643"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,30]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and hypothesis<\/jats:title>\n                    <jats:p>Aberrantly glycosylated immunoglobulin A (IgA) plays a central role in the pathogenesis of IgA nephropathy (IgAN). The activation of Toll-like receptor 9 (TLR9) has been shown to induce aberrant glycosylation of IgA via the a proliferation-inducing ligand (APRIL)-mediated pathway. TLR9 is known to be highly expressed in B cells and plasmacytoid dendritic cells (pDCs). Although the stimulation of TLR9 in B cells has been reported to promote the production of aberrantly glycosylated IgA, the effects of TLR9 stimulation on pDCs remain unclear. Therefore, in this study, we focused on the role of mucosal pDCs in the synthesis of aberrantly glycosylated IgA in patients with IgAN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We evaluated the distribution of the DC subsets in tonsillar mononuclear cells (MNCs). The synthesis of aberrantly glycosylated IgA in MNCs cultured with or without pDCs was analyzed. We also evaluated the effects of pDC depletion on the production of aberrantly glycosylated IgA in ddY mice, a spontaneous murine model of IgAN, nasally immunized with CpG-oligonucleotide, a ligand for TLR9.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The percentage of DCs, especially pDCs, was significantly higher in the palatine tonsils of patients with IgAN than in those of patients with chronic tonsillitis. In patients with IgAN, the abundance of pDCs was significantly correlated with the APRIL and TLR9 expressions in tonsillar MNCs. The levels of aberrantly glycosylated IgA in culture supernatants of tonsillar MNCs were found to be increased in the presence of pDCs. The pDC-depleted ddY mice exhibited significantly lower serum levels of aberrantly glycosylated IgA in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Mucosal pDCs contribute to the pathogenesis of IgAN by facilitating the production of aberrantly glycosylated IgA via TLR9 signaling. Our findings demonstrated that pDC may be a novel therapeutic target for IgAN.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ndt\/gfaf216","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:20:14Z","timestamp":1760530814000},"page":"888-897","source":"Crossref","is-referenced-by-count":5,"title":["Plasmacytoid dendritic cells modulate the production of mucosal IgA in IgA nephropathy"],"prefix":"10.1093","volume":"41","author":[{"given":"Yusuke","family":"Fukao","sequence":"first","affiliation":[{"name":"Juntendo University Faculty of Medicine Department of Nephrology, , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Juntendo University Faculty of Medicine Department of Nephrology, , Tokyo ,","place":["Japan"]},{"name":"Juntendo University Urayasu Hospital Department of Nephrology, , Chiba ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihito","family":"Nihei","sequence":"additional","affiliation":[{"name":"Juntendo University Faculty of Medicine Department of Nephrology, , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Makita","sequence":"additional","affiliation":[{"name":"Juntendo University Faculty of Medicine Department of Nephrology, , Tokyo ,","place":["Japan"]},{"name":"University of Toronto Department of Nephrology, ; Toronto ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Kano","sequence":"additional","affiliation":[{"name":"Juntendo University Faculty of Medicine Department of Nephrology, , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiko","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Juntendo University Faculty of Medicine Department of Nephrology, , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfeng","family":"Lee","sequence":"additional","affiliation":[{"name":"Juntendo University Faculty of Medicine Department of Nephrology, , Tokyo ,","place":["Japan"]},{"name":"Juntendo University Urayasu Hospital Department of Nephrology, , Chiba ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Kato","sequence":"additional","affiliation":[{"name":"Juntendo University Faculty of Medicine Department of Nephrology, , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Kihara","sequence":"additional","affiliation":[{"name":"Juntendo University Faculty of Medicine Department of Nephrology, , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4077-9747","authenticated-orcid":false,"given":"Yusuke","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Juntendo University Faculty of Medicine Department of Nephrology, , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"2026043010393247300_bib1","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/S0272-6386(88)80021-0","article-title":"Worldwide perspective of IgA nephropathy","volume":"12","author":"Levy","year":"1988","journal-title":"Am J Kidney Dis"},{"key":"2026043010393247300_bib2","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1056\/NEJMra1206793","article-title":"IgA nephropathy","volume":"368","author":"Wyatt","year":"2013","journal-title":"N Engl J Med"},{"key":"2026043010393247300_bib3","doi-asserted-by":"publisher","first-page":"16001","DOI":"10.1038\/nrdp.2016.1","article-title":"IgA nephropathy","volume":"2","author":"Lai","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2026043010393247300_bib4","first-page":"709","article-title":"The commonest glomerulonephritis in the world: IgA nephropathy","volume":"64","author":"D\u2019Amico","year":"1987","journal-title":"Q J Med"},{"key":"2026043010393247300_bib5","first-page":"939","article-title":"IgA glomerular deposits in renal disease","volume":"1","author":"Berger","year":"1969","journal-title":"Transplant Proc"},{"key":"2026043010393247300_bib6","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1046\/j.1523-1755.2001.060003969.x","article-title":"Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients","volume":"60","author":"Allen","year":"2001","journal-title":"Kidney Int"},{"key":"2026043010393247300_bib7","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1046\/j.1523-1755.2001.0590031077.x","article-title":"Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy","volume":"59","author":"Hiki","year":"2001","journal-title":"Kidney Int"},{"key":"2026043010393247300_bib8","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.kint.2017.10.019","article-title":"IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis","volume":"93","author":"Suzuki","year":"2018","journal-title":"Kidney Int"},{"key":"2026043010393247300_bib9","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1093\/ndt\/gfv221","article-title":"Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy","volume":"30","author":"Yasutake","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2026043010393247300_bib10","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/sj.ki.5002185","article-title":"Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels","volume":"71","author":"Moldoveanu","year":"2007","journal-title":"Kidney Int"},{"key":"2026043010393247300_bib11","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1016\/j.ekir.2022.09.022","article-title":"Clinical significance of the intensity of glomerular galactose-deficient IgA1 deposition in IgA nephropathy","volume":"7","author":"Nakayama","year":"2022","journal-title":"Kidney Int Rep"},{"key":"2026043010393247300_bib12","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00281-021-00871-y","article-title":"The mucosal immune system and IgA nephropathy","volume":"43","author":"Gesualdo","year":"2021","journal-title":"Semin Immunopathol"},{"key":"2026043010393247300_bib13","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.3390\/biomedicines10123027","article-title":"Mucosal immune system dysregulation in the pathogenesis of IgA nephropathy","volume":"10","author":"Kano","year":"2022","journal-title":"Biomedicines"},{"key":"2026043010393247300_bib14","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.kint.2021.04.026","article-title":"Nasal-associated lymphoid tissue is the major induction site for nephritogenic IgA in murine IgA nephropathy","volume":"100","author":"Kano","year":"2021","journal-title":"Kidney Int"},{"key":"2026043010393247300_bib15","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.kint.2023.08.013","article-title":"The nucleotide-sensing toll-like receptor 9\/toll-like receptor 7 system is a potential therapeutic target for IgA nephropathy","volume":"104","author":"Lee","year":"2023","journal-title":"Kidney Int"},{"key":"2026043010393247300_bib16","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.kint.2019.08.022","article-title":"TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy","volume":"97","author":"Makita","year":"2020","journal-title":"Kidney Int"},{"key":"2026043010393247300_bib17","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1681\/ASN.2016050496","article-title":"Toll-like receptor 9 stimulation induces aberrant expression of a proliferation-inducing ligand by tonsillar germinal center B cells in IgA nephropathy","volume":"28","author":"Muto","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2026043010393247300_bib18","doi-asserted-by":"publisher","first-page":"7202","DOI":"10.1128\/IAI.72.12.7202-7211.2004","article-title":"Toll-like receptor 9 can be expressed at the cell surface of distinct populations of tonsils and human peripheral blood mononuclear cells","volume":"72","author":"Eaton-Bassiri","year":"2004","journal-title":"Infect Immun"},{"key":"2026043010393247300_bib19","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1084\/jem.194.6.863","article-title":"Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens","volume":"194","author":"Kadowaki","year":"2001","journal-title":"J Exp Med"},{"key":"2026043010393247300_bib20","doi-asserted-by":"publisher","first-page":"1259989","DOI":"10.3389\/fimmu.2023.1259989","article-title":"Surface toll-like receptor 9 on immune cells and its immunomodulatory effect","volume":"14","author":"Kou","year":"2023","journal-title":"Front Immunol"},{"key":"2026043010393247300_bib21","doi-asserted-by":"publisher","first-page":"812774","DOI":"10.3389\/fimmu.2022.812774","article-title":"Toll-like receptor signaling and its role in cell-mediated immunity","volume":"13","author":"Duan","year":"2022","journal-title":"Front Immunol"},{"key":"2026043010393247300_bib22","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nri3477","article-title":"The role of dendritic cells in autoimmunity","volume":"13","author":"Ganguly","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"2026043010393247300_bib23","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/ni829","article-title":"DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL","volume":"3","author":"Litinskiy","year":"2002","journal-title":"Nat Immunol"},{"key":"2026043010393247300_bib24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.immuni.2011.02.002","article-title":"Prominent role for plasmacytoid dendritic cells in mucosal T cell-independent IgA induction","volume":"34","author":"Tezuka","year":"2011","journal-title":"Immunity"},{"key":"2026043010393247300_bib25","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.3389\/fimmu.2019.01891","article-title":"Regulation of IgA production by intestinal dendritic cells and related cells","volume":"10","author":"Tezuka","year":"2019","journal-title":"Front Immunol"},{"key":"2026043010393247300_bib26","doi-asserted-by":"publisher","first-page":"7.8.1","DOI":"10.1002\/0471142735.im0708s86","article-title":"Isolation of mononuclear cells from tonsillar tissue","volume":"Chapter 7","author":"Johnston","year":"2009","journal-title":"Curr Protoc Immunol"},{"key":"2026043010393247300_bib27","doi-asserted-by":"publisher","first-page":"6037","DOI":"10.4049\/jimmunol.165.11.6037","article-title":"BDCA-2. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood","volume":"165","author":"Dzionek","year":"2000","journal-title":"J Immunol"},{"key":"2026043010393247300_bib28","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.4049\/jimmunol.1801191","article-title":"Human blood and tonsil plasmacytoid dendritic cells display similar gene expression profiles but exhibit differential Type I IFN responses to influenza A virus infection","volume":"202","author":"Vangeti","year":"2019","journal-title":"J Immunol"},{"key":"2026043010393247300_bib29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3389\/fimmu.2016.00197","article-title":"CD1c-related DCs that express CD207\/langerin, but are distinguishable from Langerhans cells, are consistently present in human tonsils","volume":"7","author":"De Monte","year":"2016","journal-title":"Front Immunol"},{"key":"2026043010393247300_bib30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/sj.ki.5002300","article-title":"Th1 polarization in murine IgA nephropathy directed by bone marrow-derived cells","volume":"72","author":"Suzuki","year":"2007","journal-title":"Kidney Int"},{"key":"2026043010393247300_bib31","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.ajpath.2012.06.038","article-title":"Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes","volume":"181","author":"Hashimoto","year":"2012","journal-title":"Am J Pathol"},{"key":"2026043010393247300_bib32","first-page":"56","article-title":"The revival of CpG oligonucleotide-based cancer immunotherapies","volume":"22","author":"Adamus","year":"2018","journal-title":"Contemp Oncol (Pozn)"},{"key":"2026043010393247300_bib33","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1681\/ASN.2011050464","article-title":"The pathophysiology of IgA nephropathy","volume":"22","author":"Suzuki","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2026043010393247300_bib34","doi-asserted-by":"publisher","first-page":"e1139","DOI":"10.1002\/cti2.1139","article-title":"Plasmacytoid dendritic cell biology and its role in immune-mediated diseases","volume":"9","author":"Ye","year":"2020","journal-title":"Clin Transl Immunology"},{"key":"2026043010393247300_bib35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa2305635","article-title":"A Phase 2 trial of sibeprenlimab in patients with IgA nephropathy","volume":"390","author":"Mathur","year":"2024","journal-title":"N Engl J Med"},{"key":"2026043010393247300_bib36","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.kint.2019.01.031","article-title":"A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy","volume":"96","author":"Myette","year":"2019","journal-title":"Kidney Int"},{"key":"2026043010393247300_bib37","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ng.3118","article-title":"Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens","volume":"46","author":"Kiryluk","year":"2014","journal-title":"Nat Genet"},{"key":"2026043010393247300_bib38","doi-asserted-by":"publisher","first-page":"4532409","DOI":"10.1155\/2017\/4532409","article-title":"Increased abundance of plasmacytoid dendritic cells and interferon-alpha induces plasma cell differentiation in patients of IgA nephropathy","volume":"2017","author":"Zheng","year":"2017","journal-title":"Mediators Inflamm"},{"key":"2026043010393247300_bib39","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s11255-019-02365-1","article-title":"The therapeutic effect of dendritic cells expressing indoleamine 2,3-dioxygenase (IDO) on an IgA nephropathy mouse model","volume":"52","author":"Liu","year":"2020","journal-title":"Int Urol Nephrol"},{"key":"2026043010393247300_bib40","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1681\/ASN.2007121311","article-title":"Toll-like receptor 9 affects severity of IgA nephropathy","volume":"19","author":"Suzuki","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 1","key":"2026043010393247300_bib41","article-title":"#4337 Updated interim results of a phase 1\/2 study of BION-1301 in patients with IgA nephropathy","volume":"38","author":"Barratt","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2026043010393247300_bib42","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.kint.2024.03.012","article-title":"A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy","volume":"105","author":"Lafayette","year":"2024","journal-title":"Kidney Int"},{"key":"2026043010393247300_bib43","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1056\/NEJMoa2118025","article-title":"Trial of anti-BDCA2 antibody litifilimab for systemic lupus erythematosus","volume":"387","author":"Furie","year":"2022","journal-title":"N Engl J Med"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfaf216\/64718507\/gfaf216.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/5\/888\/64718507\/gfaf216.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/5\/888\/64718507\/gfaf216.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:39:39Z","timestamp":1777559979000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/41\/5\/888\/8287756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":43,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,10,16]]},"published-print":{"date-parts":[[2026,4,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfaf216","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2025,10,16]]}}}